After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.

The latest update is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ). Imricor Medical Systems has ...

BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.

Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the singer told Rolling Stone that it nearly killed him. And the way he got ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Trigeminal neuralgia (TN) is a debilitating, chronic syndrome that causes sudden, severe, electric shock-like pain in the face. While TN isn’t life-threatening, it can severely alter quality of life ...

Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...

Non-small cell lung cancer (NSCLC) remains the most prevalent type of lung cancer and a leading cause of cancer-related mortality worldwide. Surgical ...